Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201201095 Principal Investigator: Vij, Ravi
Title: A Phase 2, Randomized Study of Bortezomib/dexamethasone With or Without Elotuzumab in Subjects with Relapsed/Refractory Multiple Myeloma
Phase: II Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this study is to determine if the drug elotuzumab given with the drugs bortezomib and dexamethasone is more effective in the treatment of relapsed or refractory multiple myeloma compared with a standard treatment of bortezomib and dexamethasone alone.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)